Ried, M. and Speth, U. and Potzger, T. and Neu, R. and Diez, C. and Klinkhammer-Schalke, M. and Hofmann, H. -S. (2013) Regional treatment of malignant pleural mesothelioma. Results from the tumor centre Regensburg. CHIRURG, 84 (11). 987-+. ISSN 0009-4722, 1433-0385
Full text not available from this repository. (Request a copy)Abstract
Malignant pleural mesothelioma (MPM) is an aggressive, malignant tumor of the pleural surface and is strongly associated with asbestos exposure. Incidence of MPM will reach its peak over the coming years. Most patients present with advanced tumor stages and therefore surgical options are limited. Retrospective analysis of all patients with MPM reported to the tumor centre Regensburg between January 1998 and August 2011. A total of 118 patients (85 % male) with cytologically or histologically confirmed MPM were reported. The mean age at diagnosis was 67 years (range 45-84 years) and 65 % of patients had a history of asbestos exposure. The incidence of MPM at the tumor centre Regensburg was 0.8/100,000 inhabitants with obvious regional differences depending on asbestos exposure. Staging was completed in 81 patients (67 %): stage I 9 %, stage II 22 %, stage III 23 % and stage IV 46 %. Of the patients 87 (74 %) underwent at least one surgical procedure: diagnostic thoracoscopy with biopsy (n = 37, 43 %), debulking surgery or talcum pleurodesis (n = 33, 38 %) and potentially curative resection (n = 17, 19 %). After a mean follow-up of 20 months the overall median survival was 14 months (1 year survival rate 62 %, 3 year survival rate 15 %). Patients had a significantly better median survival of 18 months after curative resection. The distribution of MPM varies according to regional and industrial asbestos exposure. Screening and diagnostics should concentrate on locations with higher incidence of MPM to facilitate surgical therapy in a multimodal treatment regime.
| Item Type: | Article |
|---|---|
| Uncontrolled Keywords: | PHASE-II TRIAL; EXTRAPLEURAL PNEUMONECTOMY; INDUCTION CHEMOTHERAPY; SURGICAL-TREATMENT; MANAGEMENT; CISPLATIN; THERAPY; PLEURECTOMY/DECORTICATION; FEASIBILITY; RADIATION; Malignant pleural mesothelioma; Asbestos exposure; Epidemiology; Pleurectomy/decortication; Chemotherapy perfusion |
| Subjects: | 600 Technology > 610 Medical sciences Medicine |
| Divisions: | Medicine > Lehrstuhl für Herz-, Thorax- und herznahe Gefäßchirurgie Medicine > Abteilung für Thoraxchirurgie Medicine > Zentren des Universitätsklinikums Regensburg > Tumorzentrum e.V. |
| Depositing User: | Dr. Gernot Deinzer |
| Date Deposited: | 25 Mar 2020 10:51 |
| Last Modified: | 25 Mar 2020 10:51 |
| URI: | https://pred.uni-regensburg.de/id/eprint/15757 |
Actions (login required)
 |
View Item |
